Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 3 3Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3Thoracic 2Other 2Gynecologic 2Genitourinary 2Breast 2Plasma cell 1Other solid neoplasm 1Other neoplasm 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Neoplasms 2Neoplasm Metastasis 1

Interventions

Carboplatin 8Paclitaxel 7Fluorouracil 7Cisplatin 7atezolizumab 5Trastuzumab 5Pemetrexed 5Oxaliplatin 5Leucovorin 5Bevacizumab 5pembrolizumab 4Gemcitabine 4Capecitabine 4Albumin-Bound Paclitaxel 4Surveys and Questionnaires 3Observation 3Leuprolide 3Irinotecan 3Glutamine 3Drug Therapy 3Docetaxel 3Dexamethasone 3130-nm albumin-bound paclitaxel 3trifluridine tipiracil drug combination 2regorafenib 2osimertinib 2enzalutamide 2Surgical Procedures, Operative 2Standard of Care 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Surveys and Questionnaires × Tumor-Agnostic × Clear all
NCT05351294 2026-01-07

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

Rutgers, The State University of New Jersey

Phase 3 Suspended
156 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01579552 2025-11-12

Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer

Memorial Sloan Kettering Cancer Center

Phase 3 Active not recruiting
360 enrolled
Tumor-Agnostic

Neoplasms

NCT03839940 2025-01-29

MIST

Alliance for Clinical Trials in Oncology

Phase 3 Terminated
39 enrolled 18 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡